Media Outlets Highlight New Study at the Alzheimer’s Center at Temple on Promising Therapeutic Agent

Scientists at the Alzheimer’s Center at Temple at the Lewis Katz School of Medicine at Temple University are on the trail of a promising new therapeutic target – ABCA7, a protein known to protect from Alzheimer’s disease. A new study, published online in the journal Cells, uncovers new information about the relationship between ABCA7, cholesterol and inflammation in human brain cells. Joel Wiener, an investigator with the Alzheimer’s Center at Temple, is first author on the report, and Nicholas Lyssenko, PhD, also an investigator with the Alzheimer’s Center at Temple, is corresponding author. Scienmag and ScienceDaily highlighted the news.